Do You Need Chemotherapy — Alongside Alectinib?

Most ALK-positive lung cancer patients on alectinib do not need chemotherapy added during the time alectinib is working. NCCN and ESMO guidelines recommend alectinib as a standalone first-line treatment. Whether you specifically need anything else depends on your individual scan results and how your cancer is behaving. If your oncologist has mentioned chemotherapy, ask them directly whether that is being considered now or as a future option if your situation changes.

Alectinib works for different lengths of time in different people, and no oncologist can give you a precise figure that applies to you individually. What your team watches for is any change on your scans — which is why regular imaging is part of your follow-up plan. When resistance develops, the next steps are discussed based on what the scans show at that point. Asking your oncologist what they will look for at each appointment is a reasonable question to raise.

When alectinib stops controlling the cancer, your oncologist will assess what has changed. The next step depends on where the cancer is progressing, whether a localised change could be treated with radiation, and what molecular changes have occurred in the tumour. Chemotherapy is one of the options discussed at that point, alongside different targeted agents or a clinical trial. A repeat biopsy is sometimes done to understand why resistance has developed and to help decide what to try next.

Giving chemotherapy alongside alectinib at the same time is not a standard approach and is not something most patients receive outside a clinical trial. The two treatments work by completely different mechanisms, and the evidence for combining them in routine practice does not yet support it as a standard regimen. If you have heard this is part of your plan, confirm directly with your oncologist — it may be a trial, a sequential plan being described together, or a misunderstanding worth clearing up.

Alectinib is taken as a capsule twice a day at home — there is no intravenous line, no hospital admission for treatment, and hair loss is not typical. Chemotherapy infusions require a hospital or day care visit and often cause nausea, fatigue, and hair loss because they affect fast-growing cells across the body rather than one specific target. The side effects of alectinib — including muscle aches, swelling, and sensitivity to sunlight — are real but different in character from what most people associate with chemotherapy.

Not necessarily. Clinical trials test many different things — a new drug, a new combination, a different schedule, or a comparison between existing treatments. Being offered a trial does not mean you will automatically receive alectinib and chemotherapy together. Ask your oncologist what the trial is testing, what the experimental arm involves, and what the control arm gives you instead. Participation is always voluntary, and you are entitled to understand exactly what each option means before you decide.